About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Electroconvulsive Therapy in Clozapine-resistant Schizophrenia

Electroconvulsive Therapy in Clozapine-resistant Schizophrenia

NCT02159001·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Eila Tiihonen, MD, PhD
CONTACT
+358 295 242 204 [email protected]
Soile Hyvärinen, MD
CONTACT
+358 295 242 219 [email protected]

Lead

Niuvanniemi Hospital

Age

18–64

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

diagnosis of schizophrenia or schizoaffective disorder
treatment-resistant to clozapine
age 18 - 64 years
capacity and willingness to give informed consent

You may not be if

serious somatic illness
progressive neurological illness, recent brain damage or sequela of serious brain damage
ECT less than 3 months prior to this trial

The record

StatusUnknown

PhaseNo phase

Taking part20

StartedJun 2014

UpdatedOct 16, 2015

Conditions

Schizophrenia Schizoaffective Disorder

Where1

Niuvanniemi Hospital
Kuopio, Finland